Related Experiment Videos
Immunologic properties of human fetal mesenchymal stem cells
Cecilia Götherström1, Olle Ringdén, Charlotte Tammik
1Division of Clinical Immunology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden. Cecelia.Gotherstrom@labmed.ki.se
American Journal of Obstetrics and Gynecology
|January 30, 2004
Summary
Human fetal mesenchymal stem cells (MSCs) do not provoke immune responses in allogeneic settings. These findings suggest that fetal MSCs are promising for allogeneic transplantation due to their immunomodulatory properties.
Area of Science:
- Immunology
- Stem Cell Biology
- Transplantation Science
Background:
- Mesenchymal stem cells (MSCs) are found in adult bone marrow and fetal liver.
- Investigating the immunologic characteristics of human fetal MSCs is crucial for their therapeutic applications.
Purpose of the Study:
- To examine the immunologic properties of undifferentiated and differentiated human fetal MSCs.
- To assess the potential of fetal MSCs in allogeneic transplantation.
Main Methods:
- Flow cytometry and Western blot were used to analyze HLA class I and II expression on fetal MSCs.
- In vitro differentiation of MSCs into adipocytes and osteocytes was performed.
- Mixed lymphocyte cultures were employed to study MSC alloreactivity.
Main Results:
- Fetal MSCs expressed HLA class I but not HLA class II.
- Interferon-gamma (IFN-gamma) induced HLA class II expression on MSCs.
- Neither undifferentiated nor differentiated fetal MSCs induced allogeneic lymphocyte proliferation.
- IFN-gamma-treated fetal MSCs suppressed alloreactive lymphocytes.
Conclusions:
- Undifferentiated and differentiated fetal MSCs do not induce alloreactive lymphocyte proliferation.
- Fetal MSCs exhibit immunomodulatory potential, suggesting suitability for allogeneic transplantation.